Logo image of AIL.DE

AIR LIQUIDE SA (AIL.DE) Stock Fundamental Analysis

FRA:AIL - FR0000120073 - Common Stock

177.02 EUR
+0.1 (+0.06%)
Last: 9/9/2025, 7:00:00 PM
Fundamental Rating

5

AIL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 65 industry peers in the Chemicals industry. While AIL has a great profitability rating, there are some minor concerns on its financial health. AIL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

AIL had positive earnings in the past year.
In the past year AIL had a positive cash flow from operations.
AIL had positive earnings in each of the past 5 years.
Each year in the past 5 years AIL had a positive operating cash flow.
AIL.DE Yearly Net Income VS EBIT VS OCF VS FCFAIL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

With a decent Return On Assets value of 6.70%, AIL is doing good in the industry, outperforming 78.46% of the companies in the same industry.
AIL's Return On Equity of 13.49% is fine compared to the rest of the industry. AIL outperforms 76.92% of its industry peers.
AIL has a better Return On Invested Capital (9.87%) than 84.62% of its industry peers.
AIL had an Average Return On Invested Capital over the past 3 years of 9.47%. This is above the industry average of 7.08%.
The last Return On Invested Capital (9.87%) for AIL is above the 3 year average (9.47%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.7%
ROE 13.49%
ROIC 9.87%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
AIL.DE Yearly ROA, ROE, ROICAIL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

AIL has a better Profit Margin (12.22%) than 89.23% of its industry peers.
In the last couple of years the Profit Margin of AIL has grown nicely.
Looking at the Operating Margin, with a value of 19.93%, AIL belongs to the top of the industry, outperforming 93.85% of the companies in the same industry.
In the last couple of years the Operating Margin of AIL has grown nicely.
The Gross Margin of AIL (63.01%) is better than 92.31% of its industry peers.
AIL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.63%
GM growth 3Y1.78%
GM growth 5Y0.07%
AIL.DE Yearly Profit, Operating, Gross MarginsAIL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AIL is creating some value.
AIL has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for AIL has been increased compared to 5 years ago.
The debt/assets ratio for AIL has been reduced compared to a year ago.
AIL.DE Yearly Shares OutstandingAIL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
AIL.DE Yearly Total Debt VS Total AssetsAIL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

AIL has an Altman-Z score of 3.90. This indicates that AIL is financially healthy and has little risk of bankruptcy at the moment.
AIL has a Altman-Z score of 3.90. This is amongst the best in the industry. AIL outperforms 81.54% of its industry peers.
AIL has a debt to FCF ratio of 4.60. This is a neutral value as AIL would need 4.60 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.60, AIL is doing good in the industry, outperforming 80.00% of the companies in the same industry.
AIL has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
AIL has a Debt to Equity ratio (0.47) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.6
Altman-Z 3.9
ROIC/WACC1.37
WACC7.22%
AIL.DE Yearly LT Debt VS Equity VS FCFAIL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 0.84 indicates that AIL may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.84, AIL is doing worse than 89.23% of the companies in the same industry.
A Quick Ratio of 0.61 indicates that AIL may have some problems paying its short term obligations.
AIL's Quick ratio of 0.61 is on the low side compared to the rest of the industry. AIL is outperformed by 89.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.61
AIL.DE Yearly Current Assets VS Current LiabilitesAIL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

AIL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.10%, which is quite good.
Measured over the past years, AIL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.55% on average per year.
AIL shows a decrease in Revenue. In the last year, the revenue decreased by -1.99%.
Measured over the past years, AIL shows a small growth in Revenue. The Revenue has been growing by 4.30% on average per year.
EPS 1Y (TTM)11.1%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%-4.88%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%2.94%

3.2 Future

Based on estimates for the next years, AIL will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.10% on average per year.
AIL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.07% yearly.
EPS Next Y5.81%
EPS Next 2Y9.11%
EPS Next 3Y9.27%
EPS Next 5Y10.1%
Revenue Next Year1.47%
Revenue Next 2Y3.02%
Revenue Next 3Y3.67%
Revenue Next 5Y4.07%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AIL.DE Yearly Revenue VS EstimatesAIL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
AIL.DE Yearly EPS VS EstimatesAIL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 28.23, the valuation of AIL can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as AIL.
AIL's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.07.
AIL is valuated rather expensively with a Price/Forward Earnings ratio of 23.12.
AIL's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.59. AIL is around the same levels.
Industry RankSector Rank
PE 28.23
Fwd PE 23.12
AIL.DE Price Earnings VS Forward Price EarningsAIL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

AIL's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AIL is more expensive than 63.08% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AIL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 37.25
EV/EBITDA 14.02
AIL.DE Per share dataAIL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AIL does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of AIL may justify a higher PE ratio.
PEG (NY)4.86
PEG (5Y)2.45
EPS Next 2Y9.11%
EPS Next 3Y9.27%

4

5. Dividend

5.1 Amount

AIL has a Yearly Dividend Yield of 1.87%.
Compared to an average industry Dividend Yield of 3.00, AIL has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.46, AIL is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.87%

5.2 History

The dividend of AIL has a limited annual growth rate of 5.86%.
Dividend Growth(5Y)5.86%
Div Incr Years6
Div Non Decr Years6
AIL.DE Yearly Dividends per shareAIL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

59.10% of the earnings are spent on dividend by AIL. This is a bit on the high side, but may be sustainable.
AIL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP59.1%
EPS Next 2Y9.11%
EPS Next 3Y9.27%
AIL.DE Yearly Income VS Free CF VS DividendAIL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
AIL.DE Dividend Payout.AIL.DE Dividend Payout, showing the Payout Ratio.AIL.DE Dividend Payout.PayoutRetained Earnings

AIR LIQUIDE SA

FRA:AIL (9/9/2025, 7:00:00 PM)

177.02

+0.1 (+0.06%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-21 2025-10-21
Inst Owners27.27%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap102.40B
Analysts80
Price Target200.39 (13.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.87%
Yearly Dividend2.98
Dividend Growth(5Y)5.86%
DP59.1%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.78%
PT rev (3m)0.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.72%
EPS NY rev (3m)-3.72%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-2.14%
Valuation
Industry RankSector Rank
PE 28.23
Fwd PE 23.12
P/S 3.78
P/FCF 37.25
P/OCF 15.87
P/B 4.18
P/tB 11.2
EV/EBITDA 14.02
EPS(TTM)6.27
EY3.54%
EPS(NY)7.66
Fwd EY4.32%
FCF(TTM)4.75
FCFY2.68%
OCF(TTM)11.16
OCFY6.3%
SpS46.77
BVpS42.38
TBVpS15.81
PEG (NY)4.86
PEG (5Y)2.45
Profitability
Industry RankSector Rank
ROA 6.7%
ROE 13.49%
ROCE 13.55%
ROIC 9.87%
ROICexc 10.27%
ROICexgc 16.67%
OM 19.93%
PM (TTM) 12.22%
GM 63.01%
FCFM 10.16%
ROA(3y)6.1%
ROA(5y)5.92%
ROE(3y)12.2%
ROE(5y)12.34%
ROIC(3y)9.47%
ROIC(5y)8.98%
ROICexc(3y)9.91%
ROICexc(5y)9.43%
ROICexgc(3y)16.92%
ROICexgc(5y)16.28%
ROCE(3y)12.5%
ROCE(5y)11.85%
ROICexcg growth 3Y3.94%
ROICexcg growth 5Y3.85%
ROICexc growth 3Y4.91%
ROICexc growth 5Y4.63%
OM growth 3Y3.78%
OM growth 5Y2.86%
PM growth 3Y3.49%
PM growth 5Y3.63%
GM growth 3Y1.78%
GM growth 5Y0.07%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.6
Debt/EBITDA 1.45
Cap/Depr 144.44%
Cap/Sales 13.69%
Interest Coverage 20.74
Cash Conversion 81.12%
Profit Quality 83.16%
Current Ratio 0.84
Quick Ratio 0.61
Altman-Z 3.9
F-Score7
WACC7.22%
ROIC/WACC1.37
Cap/Depr(3y)136.72%
Cap/Depr(5y)133.49%
Cap/Sales(3y)12.08%
Cap/Sales(5y)12.32%
Profit Quality(3y)89.93%
Profit Quality(5y)95.75%
High Growth Momentum
Growth
EPS 1Y (TTM)11.1%
EPS 3Y12.6%
EPS 5Y11.55%
EPS Q2Q%-4.88%
EPS Next Y5.81%
EPS Next 2Y9.11%
EPS Next 3Y9.27%
EPS Next 5Y10.1%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y5.06%
Revenue growth 5Y4.3%
Sales Q2Q%2.94%
Revenue Next Year1.47%
Revenue Next 2Y3.02%
Revenue Next 3Y3.67%
Revenue Next 5Y4.07%
EBIT growth 1Y6.38%
EBIT growth 3Y9.02%
EBIT growth 5Y7.28%
EBIT Next Year58.93%
EBIT Next 3Y22.7%
EBIT Next 5Y16.17%
FCF growth 1Y-11.78%
FCF growth 3Y1.77%
FCF growth 5Y6.15%
OCF growth 1Y-1.15%
OCF growth 3Y4.31%
OCF growth 5Y6.05%